Clinical Trials Browser

Phase 2/3 × Unknown × Leukemia, Biphenotypic, Acute × Clear all

NCT04257175 2023-11-28

CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute